Key points from article :
Designed nanoparticles preferentially interact with cancer cells via receptors.
Can navigate directly to tumor cells, visualize using advanced imaging techniques.
In addition to antibodies, dye molecules and radionuclides were attached.
Nanoparticle accumulation in tumor tissue reaches maximum 2 days after administration.
These are subsequently eliminated via kidneys without being a burden for the body.
The next step is to combine the new technique with therapeutic approaches.
In the future, this can be functionalized with an active substance.
Like attaching therapeutic radionuclides that destroys the tumor cells.
Research by Helmholtz-Zentrum Dresden-Rossendorf (HZDR) and FU Berlin scientists.
Published in Small.
